Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons

Stem Cell Reports(2020)10.1016/j.stemcr.2019.12.005Source: DataRank Database

Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons is a research paper published in Stem Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 63 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access63 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.76)OA: goldTopics (58)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Alban Ordureau ORCID,Christina Bell ORCID,Lily Sarrafha ORCID,Chicheng Sun ORCID,Silvia Piccinotti ORCID

Live enrichment

PubMed:31902706 PMC:PMC6962705 OpenAlex:https://openalex.org/W2997890461

NINDS NIH HHS

Grant: R37 NS083524

NIGMS NIH HHS

Grant: R01 GM132129

National Institutes of Health

Biogen

Harvard Medical School

Michael J. Fox Foundation for Parkinson's Research

Harvard Stem Cell Institute

FWCI

2.76

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttp://www.cell.com/article/S2213671119304448/pdf

publisherhttp://www.cell.com/article/S2213671119304448/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213671119304448?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213671119304448?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.stemcr.2019.12.005

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingPluripotent Stem Cells ResearchCell LineDopaminergic NeuronsGene Knock-In TechniquesGenes, RecessiveGenetic Association StudiesGenetic Predisposition to DiseaseHumansMitochondriaMutationParkinson DiseasePhenotypePluripotent Stem CellsProteomeProteomicsSignal TransductionTyrosine 3-MonooxygenaseParkinson Disease 7, Autosomal Recessive Early-Onset

MeSH Terms

Cell LineGenes, RecessiveHumansMitochondriaMutationParkinson DiseasePhenotypeTyrosine 3-MonooxygenaseSignal TransductionGenetic Predisposition to DiseaseProteomePluripotent Stem CellsProteomicsGene Knock-In TechniquesGenetic Association StudiesDopaminergic Neurons

Keywords

ParkinBiologyDopaminergicInduced pluripotent stem cellParkinson's diseaseGeneticsPINK1GeneDiseaseCell biologyDopamineNeuroscienceEmbryonic stem cellInternal medicineProteomicsTranscriptomicsDisease ModelingCrisprHuman Pluripotent Stem CellsGenome EditingDj1Atp13a2

Sustainable Development Goals

SDG 0: Good health and well-being